These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 72755)

  • 21. Immunochemical studies of human fibrinopeptide A using synthetic peptide homologues.
    Wilner GD; Nossel HL; Canfield RE; Butler VP
    Biochemistry; 1976 Mar; 15(6):1209-13. PubMed ID: 1252441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proceedings: Immunochemical studies on the NH2-terminal "disulfide knot" and related structures.
    Kudryk B; Blomback B
    Thromb Diath Haemorrh; 1975 Sep; 34(1):325. PubMed ID: 1188739
    [No Abstract]   [Full Text] [Related]  

  • 23. Characterisation of the chains of human fibrinogen isolated by perfusion chromatography using fibrin specific monoclonal antibodies.
    Raut S; Corran PH; Gaffney PJ
    Thromb Res; 1995 Aug; 79(4):405-13. PubMed ID: 7482444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrinogen binds to integrin alpha(5)beta(1) via the carboxyl-terminal RGD site of the Aalpha-chain.
    Suehiro K; Mizuguchi J; Nishiyama K; Iwanaga S; Farrell DH; Ohtaki S
    J Biochem; 2000 Oct; 128(4):705-10. PubMed ID: 11011154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Markers of fibrinogen derivatives used in clinical investigation.
    Soria J; Soria C; Mirshahi M; Samama MM
    Semin Thromb Hemost; 1985 Apr; 11(2):129-32. PubMed ID: 2412296
    [No Abstract]   [Full Text] [Related]  

  • 26. [Study of the polymerization of fibrin using monoclonal antibodies 2D-2A and their Fab-fragments].
    Lugovskoĭ EV; Chudnovets VS; Makogonenko EM; Derzskaia SG; Gogolinskaia GK; Kolesnikova IN; Mikhalovskaia LI; Komissarenko SV
    Ukr Biokhim Zh (1978); 1995; 67(1):64-70. PubMed ID: 8588256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigenic properties of fibrinogen component of Hemaseel HMN subjected to the antiviral severe dry heat treatment.
    Cierniewski CS; Pluskota E; Cieslak M; Brodniewicz T; Nowotarski M
    Thromb Res; 1996 May; 82(4):349-59. PubMed ID: 8743730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen.
    Hui KY; Haber E; Matsueda GR
    Science; 1983 Dec; 222(4628):1129-32. PubMed ID: 6648524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residue gamma153Cys is essential for the formation of the complexes Aalphagamma and Bbetagamma, assembly intermediates for the AalphaBbetagamma complex and intact fibrinogen.
    Terasawa F; Fujita K; Okumura N
    Clin Chim Acta; 2005 Mar; 353(1-2):157-64. PubMed ID: 15698603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological characterization of early fibrinogen degradation products. Radioimmunoassay of fragments released from the Aalpha-chain of fibrinogen.
    Blombäck M; Blombäck B; Holmgvist H
    Thromb Res; 1976 May; 8(5):567-77. PubMed ID: 59398
    [No Abstract]   [Full Text] [Related]  

  • 31. Antigenic determinants in the disulfide regions of bovine fibrinogen.
    Timpl R; Hahn E; Gollwitzer R
    Eur J Biochem; 1975 Feb; 51(2):617-23. PubMed ID: 50233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors.
    Hawiger J; Timmons S; Kloczewiak M; Strong DD; Doolittle RF
    Proc Natl Acad Sci U S A; 1982 Mar; 79(6):2068-71. PubMed ID: 6281794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactivity of fibrinogen and fibrinopeptide A containing fibrinogen fragments with antisera to fibrinopeptide A.
    Canfield RE; Dean J; Nossel HL; Butler VP; Wilner GD
    Biochemistry; 1976 Mar; 15(6):1203-9. PubMed ID: 943180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-idiotypic antibodies against an antibody to the platelet glycoprotein (GP) IIb-IIIa complex mimic GP IIb-IIIa by recognizing fibrinogen.
    Abrams CS; Ruggeri ZM; Taub R; Hoxie JA; Nagaswami C; Weisel JW; Shattil SJ
    J Biol Chem; 1992 Feb; 267(4):2775-85. PubMed ID: 1370832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and characterization of a specific antibody population against human fibrinogen.
    Lau HK; Cheung M; Siu A
    Biochem Int; 1987 Sep; 15(3):561-9. PubMed ID: 2447894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody-detectable changes in fibrinogen adsorption affecting platelet activation on polymer surfaces.
    Shiba E; Lindon JN; Kushner L; Matsueda GR; Hawiger J; Kloczewiak M; Kudryk B; Salzman EW
    Am J Physiol; 1991 May; 260(5 Pt 1):C965-74. PubMed ID: 2035620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A monoclonal antibody with ability to distinguish between NH2-terminal fragments derived from fibrinogen and fibrin.
    Kudryk B; Rohoza A; Ahadi M; Chin J; Wiebe ME
    Mol Immunol; 1983 Nov; 20(11):1191-200. PubMed ID: 6656769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Location of peptide fragments in the fibrinogen molecule by immunoelectron microscopy.
    Telford JN; Nagy JA; Hatcher PA; Scheraga HA
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2372-6. PubMed ID: 6769127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localization and characterization of the cleavage-associated neoantigen locus in the E domain of fibrinogen.
    Plow EF; Edgington TS
    J Biol Chem; 1979 Feb; 254(3):672-8. PubMed ID: 83993
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunochemical distinction between two different chains of type IV collagen.
    Risteli J; Schuppan D; Glanville RW; Timpl R
    Biochem J; 1980 Nov; 191(2):517-22. PubMed ID: 6165353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.